Kemira Oyj - Company Announcement

Kemira Oyj: Members of the Nomination Board

Kemira Oyj
Stock Exhange Release
September 12, 2013 at 11.00 am (CET+1)

According to the decision of the Kemira Oyj's Annual General Meeting, the
Nomination Board consists of representatives of the four largest shareholders of
Kemira Oyj as of August 31 preceding the Annual General Meeting and the Chairman
of the Board of Directors of the Company as an expert member.

Based on the ownership status of Kemira Oyj as of August 31, 2013, the
shareholders represented in the Nomination Board are Oras Invest Oy, Solidium
Oy, Varma Mutual Pension Insurance Company and Ilmarinen Mutual Pension
Insurance Company.

The representatives of the four largest shareholders in the Nomination Board are
Pekka Paasikivi, Chairman of the Board of Oras Invest Oy; Kari Järvinen,
Managing Director of Solidium Oy; Risto Murto, Executive Vice President, Varma
Mutual Pension Insurance Company and Timo Ritakallio, Deputy CEO, Ilmarinen
Mutual Pension Insurance Company. Jukka Viinanen, Chairman of Kemira's Board of
Directors acts as an expert member.

The tasks of the Nomination Board are annually

- preparation of the proposal for the Annual General Meeting concerning the
composition of the Board of Directors;
- preparation of the proposal for the Annual General Meeting concerning the
remuneration of the Board of Directors;
- identification of successor candidates for the members of the Board of
Directors; and
- presentation of the proposal concerning the composition and remuneration of
the Board of Directors to the Annual General Meeting.


For more information, please contact

Kemira Oyj
Jukka Hakkila, Group General Counsel
Tel. +358 10 862 1690

Tero Huovinen, Vice President, Investor Relations
Tel. +358 10 862 1980


Kemira is a global chemicals company serving customers in water-intensive
industries. We provide expertise and chemicals that improve our customers'
water, energy and raw material efficiency. Our focus is on pulp & paper, oil &
gas, mining and water treatment. In 2012, Kemira had annual revenue of EUR 2.2
billion and around 4,900 employees. Kemira shares are listed on the NASDAQ OMX
Helsinki Ltd.
www.kemira.com

[HUG#1728793]

Bifogade filer:

Link to the release.pdf